Company Overview and News


Add GLAXO
to your dashboard

Headline News

GSK Pharma Q2 net profit up 32% at Rs 130 cr

2017-10-25 business-standard
Drug firm GlaxoSmithKline Pharmaceuticals on Wednesday reported a 31.83 per cent rise in standalone net profit to Rs 130.32 crore for the second quarter ended September 30, 2017. The company had posted a net profit of Rs 98.85 crore for the corresponding period of the previous fiscal, GlaxoSmithKline Pharmaceuticals said in a filing to BSE.

GlaxoSmithKline profit rises 32% in Q2 led by recovery of inventory levels

2017-10-25 moneycontrol
GlaxoSmithKline Pharmaceuticals on Wednesday posted a 32 percent increase in net profit to Rs 130.3 crore in the second quarter ended September 30, helped by the recovery of inventories in trade channels which were hit by GST rollout.

GlaxoSmithKline Pharmaceuticals Limited - Press Release

2017-10-25 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information. (15-0)

GSK Pharma Q2 profit up 32% at Rs130 crore

2017-10-25 livemint
New Delhi: Drug firm GlaxoSmithKline Pharmaceuticals (GSK Pharma) on Wednesday reported a 31.83% rise in standalone net profit to Rs130.32 crore for the second quarter ended 30 September, 2017.

GlaxoSmithKline Pharmaceuticals Limited - Appointment

2017-10-25 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information. (15-0)

GlaxoSmithKline Pharma Q2 net up 32% at Rs 130 cr

2017-10-25 thehindubusinessline
Drug firm GlaxoSmithKline Pharmaceuticals today reported a 31.83 per cent rise in standalone net profit to Rs 130.32 crore for the second quarter ended September 30, 2017.

GlaxoSmithKline Pharmaceuticals Limited - Financial Result Updates

2017-10-25 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information. (15-0)

MobileHelp(R) Healthcare Appoints Jerriene Cordova as Director of Telehealth Programs, Telehealth

2017-10-16 marketwired
BOCA RATON, FL--(Marketwired - October 16, 2017) - MobileHelp® Healthcare, a leader in mobile Personal Emergency Response System (mPERS) and health management solutions, today announced the appointment of Jerriene Cordova as Director of Telehealth Programs. Ms. Cordova brings more than two decades of experience in developing new markets and building strategic alliances.

Expect Rs 280-285 crore of topline in Sorbitol segment: Gulshan Polyols

2017-10-13 moneycontrol
In an interview to CNBC-TV18, Rajesh Agrawal, CFO of Gulshan Polyols spoke about the latest happenings in the company and his outlook going ahead. (42-0)

Land monetisation picks up post RERA

2017-10-11 livemint
Mumbai: Developers and land owners are rushing to monetise land parcels either through outright sale or by partnering with a larger builder to jointly develop them due to the changing regulatory environment, piling debts and prolonged slowdown in the property market.

GlaxoSmithKline Pharmaceuticals Limited - Trading Window

2017-10-03 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information. (15-0)

Vaidheesh elected OPPI chief

2017-09-26 thehindubusinessline
The Organisation of Pharmaceutical Producers of India has unanimously elected GlaxoSmithKline India chief A. Vaidheesh as its new President. (16-0)

Oberoi Realty soars 7% as analysts remain bullish post residential project from GSK

2017-09-25 moneycontrol
Oberoi Realty share price rallied 7.4 percent intraday Monday to hit a fresh 52-week high of Rs 437.50, following residential project from GlaxoSmithKline Pharmaceuticals. (52-0)

Realty stocks tank up to 5%

2017-09-25 thehindubusinessline
Realty stocks such as Indiabulls Real Estate, Unitech, Phoenix Mills, Delta Corp, Housing Development & Infrastructure and Prestige Estates Projects tanked up to 5 per cent on Monday, causing Nifty Realty index extend the losses for the fourth session.